Does erythropoietin accelerate malignant transformation in multiple myeloma?

Postgraduate Medical Journal

Volumn 73, Issue 857, 1997, Pages 163-164

  Olujohungbe, A ^a  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Erythropoietin; Malignant transformation; Multiple myeloma

Indexed keywords

ERYTHROPOIETIN RECEPTOR; RECOMBINANT ERYTHROPOIETIN;

ADULT; ANEMIA; ARTICLE; CASE REPORT; CELL LINEAGE; HEMATOPOIESIS; HUMAN; KIDNEY FAILURE; MALE; MALIGNANT TRANSFORMATION; MULTIPLE MYELOMA; MYELOMA CELL; PLASMA CELL LEUKEMIA;

EID: 0030901175     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.73.857.163     Document Type: Article

References (3)

1. MacLennan ICMM, Drayson M, Dunn J. Current issues in cancer. Multiple myeloma. BMJ 1994; 308: 1033-6.
2. Ludwig H, Fritz E, Kotzmann H,Hocker P,Gisslinger H, Barnas U. Erythropoietin treatment of anaemia associated with multiple myeloma. N Engl J Med 1990; 322: 1693-9.
3. Caillette A, Barreto S, Gimenez E, Labeeuw M, Zech P. Is erythropoietin treatment safe and effective in myeloma patients receiving haemodialysis? Clin Nephrol 1993; 40: 176-8.